Skip to Main Content

Paper Details

Attitudes toward pharmacogenetics in patients undergoing <i>CYP2C19</i> testing following percutaneous coronary intervention.
Per Med
3
2022
PGx, Patient, patient, patients
Author NameAffiliation
William H MatthaiUniversity of Pennsylvania Perelman School of Medicine
Daniel M KolanskyUniversity of Pennsylvania Perelman School of Medicine
Sony TutejaUniversity of Pennsylvania Perelman School of Medicine
  • 1 - 3

Datasets

Release 1.2